Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech IncfiledCriticalGenentech Inc
Priority claimed from PCT/US2014/042560external-prioritypatent/WO2015023355A1/en
Publication of MA38812A1publicationCriticalpatent/MA38812A1/en
Publication of MA38812B1publicationCriticalpatent/MA38812B1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
L'invention concerne des conjugués anticorps-médicament comprenant un anticorps conjugué avec une fraction médicament dimérique 1-(chlorométhyl)-2,3-dihydro-1h-benzo[e]indole(cbi), ainsi que des méthodes d'utilisation desdits conjugués anticorps-médicament.The invention relates to antibody-drug conjugates comprising an antibody conjugated with a 1- (chloromethyl) -2,3-dihydro-1H-benzo [e] indole dimeric drug moiety (cbi), as well as methods of using such conjugates antibody-drug.
MA38812A2013-08-122014-06-16
1- (Chloromethyl) -2,3-dihydro-1H-benzo [e] indole antibody-drug conjugates, and methods of use and treatment
MA38812B1
(en)
Pharmaceutical dosage form comprising 6-fluoro - (n-methyl-or n, n-dimethyl) -4-phenyl -4,9-dihydro-3h-spiro - (cyclohexan-1,1-pyran (3,4, b) indole) -4-amine, useful as an analgesic